The vascular endothelial injury occurs in severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) infections, but the mechanisms are poorly understood. We sought to …

The outbreak of coronavirus disease 2019 (COVID-19) caused by the betacoronavirus
SARS-CoV-2 is now a worldwide challenge for healthcare systems. Although the leading …

Severe coronavirus disease-19 (COVID-19) is characterized by vascular inflammation and
thrombosis. We and others have proposed that the inflammatory response to coronavirus …

Rationale: Autopsy and biomarker studies suggest that endotheliopathy contributes to
coronavirus disease (COVID-19)-associated acute respiratory distress syndrome. However …

The ongoing pandemic of coronavirus disease 2019 (COVID-19) caused by the acute
respiratory syndrome-coronavirus-2 (SARS-CoV-2) poses a persistent threat to global public …

Beside the commonly described pulmonary expression of the coronavirus disease 2019
(COVID-19), major vascular events have been reported. The objective of this study was to …

Introduction SARS-CoV-2 infection causes severe endothelial damage, an essential step for
cardiovascular complications. Endothelial-colony forming cells (ECFCs) act as a biomarker …

Objective: Whether endotheliopathy only mirrors coronavirus disease 2019 (COVID-19)
severity or plays an intrinsic role in microvascular thrombosis and organ failure remains …

Systemic inflammatory response, as observed in sepsis and severe COVID-19, may lead to
endothelial damage. Therefore, we aim to compare the extent of endothelial injury and its …

Systemic microvascular dysfunction has been shown to be present in COVID-19, and serum
cytokines are known to be involved in the regulation of vascular function. We sought to …